| Liwei E Huang, MD | |
|
300 Medical Pkwy, Suite 110, Chesapeake, VA 23320-4985 | |
| (757) 623-0005 | |
| (757) 410-7349 |
| Full Name | Liwei E Huang |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 33 Years |
| Location | 300 Medical Pkwy, Chesapeake, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912174939 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 0101253549 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kempsville Dialysis | Virginia beach, VA | Dialysis facility |
| Great Bridge Dialysis Center | Chesapeake, VA | Dialysis facility |
| Chesapeake Regional Medical Center | Chesapeake, VA | Hospital |
| Sentara Princess Anne Hospital | Virginia beach, VA | Hospital |
| Sentara Obici Hospital | Suffolk, VA | Hospital |
| Sentara Leigh Hospital | Norfolk, VA | Hospital |
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tidewater Kidney Specialists Inc | 6507852662 | 21 |
News Archive
More than $18 million in grants to spur the development of a third generation of DNA sequencing technologies was announced today by the National Human Genome Research Institute (NHGRI). The new technologies will sequence a person's DNA quickly and cost-effectively so it routinely can be used by biomedical researchers and health care workers to improve the prevention, diagnosis and treatment of human disease.
A reproductive hormone helps regulate food intake and energy metabolism without causing adverse effects, a new animal study finds. The results will be presented Monday at The Endocrine Society's 94th Annual Meeting in Houston.
The Center for Reproductive Rights issued the following statement from Nancy Northup, president of the Center for Reproductive Rights, in response to the FDA announcement regarding Plan B.
A study performed by an international team led by the Barcelona Institute for Global Health (ISGlobal), a center supported by the "la Caixa" Foundation, reports a link between exposure to blue light at night and higher risk of developing breast and prostate cancer.
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal - such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.
› Verified 5 days ago
| Entity Name | Tidewater Kidney Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780624627 PECOS PAC ID: 6507852662 Enrollment ID: O20040519001509 |
News Archive
More than $18 million in grants to spur the development of a third generation of DNA sequencing technologies was announced today by the National Human Genome Research Institute (NHGRI). The new technologies will sequence a person's DNA quickly and cost-effectively so it routinely can be used by biomedical researchers and health care workers to improve the prevention, diagnosis and treatment of human disease.
A reproductive hormone helps regulate food intake and energy metabolism without causing adverse effects, a new animal study finds. The results will be presented Monday at The Endocrine Society's 94th Annual Meeting in Houston.
The Center for Reproductive Rights issued the following statement from Nancy Northup, president of the Center for Reproductive Rights, in response to the FDA announcement regarding Plan B.
A study performed by an international team led by the Barcelona Institute for Global Health (ISGlobal), a center supported by the "la Caixa" Foundation, reports a link between exposure to blue light at night and higher risk of developing breast and prostate cancer.
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal - such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Liwei E Huang, MD 4445 Corporation Ln Ste 100, Virginia Beach, VA 23462-3666 Ph: (757) 623-0005 | Liwei E Huang, MD 300 Medical Pkwy, Suite 110, Chesapeake, VA 23320-4985 Ph: (757) 623-0005 |
News Archive
More than $18 million in grants to spur the development of a third generation of DNA sequencing technologies was announced today by the National Human Genome Research Institute (NHGRI). The new technologies will sequence a person's DNA quickly and cost-effectively so it routinely can be used by biomedical researchers and health care workers to improve the prevention, diagnosis and treatment of human disease.
A reproductive hormone helps regulate food intake and energy metabolism without causing adverse effects, a new animal study finds. The results will be presented Monday at The Endocrine Society's 94th Annual Meeting in Houston.
The Center for Reproductive Rights issued the following statement from Nancy Northup, president of the Center for Reproductive Rights, in response to the FDA announcement regarding Plan B.
A study performed by an international team led by the Barcelona Institute for Global Health (ISGlobal), a center supported by the "la Caixa" Foundation, reports a link between exposure to blue light at night and higher risk of developing breast and prostate cancer.
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal - such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.
› Verified 5 days ago
Barbara Sarris, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4041 Taylor Rd, Suite G, Chesapeake, VA 23321 Phone: 757-484-5828 Fax: 757-484-4371 | |
Dr. Jieming Yan, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 736 Battlefield Blvd N, Chesapeake, VA 23320 Phone: 757-967-8622 Fax: 757-686-0541 | |
Louis Nicondro Carideo, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 808 S Battlefield Blvd, Chesapeake, VA 23322 Phone: 757-482-4721 Fax: 757-546-9108 | |
Himanshu D. Desai, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 710 Liberty St, Chesapeake, VA 23324 Phone: 757-312-8121 | |
Paul J Pontier, MD Nephrology Medicare: Medicare Enrolled Practice Location: 713 Volvo Pkwy, Ste 100, Chesapeake, VA 23320 Phone: 757-548-0076 Fax: 757-548-1652 | |
Alan J. Gamsey, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 112 Gainsborough Sq, Suite 200, Chesapeake, VA 23320 Phone: 757-547-0798 Fax: 757-547-0145 | |
Dr. David Howell Lasseter, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 713 Volvo Pkwy Ste 101, Chesapeake, VA 23320 Phone: 757-609-3404 Fax: 757-410-7215 |